Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1982:32:195-212.

Treating the depressed elderly patient: the comparative behavioral pharmacology of mianserin and amitriptyline

R J Branconnier, J O Cole, S Ghazvinian, S Rosenthal
  • PMID: 7046364
Clinical Trial

Treating the depressed elderly patient: the comparative behavioral pharmacology of mianserin and amitriptyline

R J Branconnier et al. Adv Biochem Psychopharmacol. 1982.

Abstract

MIA is an effective antidepressant, comparable in therapeutic efficacy to the TCAs. Further, because of its weak antimuscarinic effects. Further, because of its weak antimuscarinic effects, MIA produces no significant cognitive impairment, alteration of cardiovascular function of anticholinergic side effects compared to the TCA's. While drowsiness is the most frequently reported adverse reaction with MIA, an h.s. dosing schedule can provide relief of insomnia and improve the quality of sleep (47,61). Therefore, because of MIA's advantageous pharmacodynamic profile, it offers an improvement in therapeutic index over the TCAs in the treatment of depression in the elderly.

PubMed Disclaimer